| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 398,957 | 362,635 | 339,677 | 391,212 | | Cost of Revenue | (663,294) | 322,547 | 340,747 | 459,827 | | | Gross Profit | 1,062,251 | 40,088 | (1,070) | (68,615) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative |
-
| 49,769 | 9,638 | (70,768) | | Non Recurring |
-
| (244) | (717) | (726) | | Others |
-
| 17,861 | 18,610 | 18,681 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (12,237) | (27,298) | (28,601) | (15,802) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,779 | 2,117 | (152) | (1,018) | | Earnings Before Interest And Taxes | (9,458) | (25,181) | (28,753) | (16,820) | | Interest Expense | 356 | 344 | 341 | 300 | | Income Before Tax | (9,814) | (25,525) | (29,094) | (17,120) | | Income Tax Expense | (4,565) | (10,082) | (10,937) | (6,146) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,573) | (15,443) | (18,157) | (10,974) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,573) | (15,443) | (18,157) | (10,974) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,573) | ($15,443) | ($18,157) | ($10,974) |
|
0.51% Nasdaq 
0.15 (0.47%) 
Income Statement
